Rise of long-acting injectable antipsychotic drugs reshaping local market

Long-acting, atypical injectable antipsychotic drugs has been in the spotlight here, despite the fact that most oral atypical antipsychotics have lost patent exclusivity over the past three years, resulting in an annual growth rate of -12 percent.

Korea’s antipsychotic drug market is estimated to be sized at 140 billion won in 2002, but is losing its momentum due to a bigger market share of...